Difficulties Managing Spinal Deformities in Congenital Insensitivity to Pain with Anhidrosis
JBJS Case Connector · 2026-10 · 16 (4)
DOI: 10.2106/jbjs.cc.26.00441 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBJS Case Connector, 2026-10. Verfasst von Álvaro Cerezal und 5 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Case: A 15-year-old girl with congenital insensitivity to pain with anhidrosis (CIPA) consulted for thoracolumbar kyphosis and L5 spondylolysis, later developing bilateral L5 paresis and sphincter dysfunction. Imaging showed L5-S1 destruction with epidural collection; after negative biopsies, decompression alone was performed. The lesion progressed to L5 spondyloptosis within 9 months. Staged L3-pelvis fusion and anterior reconstruction with a microvascular fibular graft were undertaken. Over 7 years, recurrent osteolysis, instrumentation failure, and infection required eventual instrumentation removal and skin coverage. Conclusion: Charcot spondyloarthropathy in CIPA progresses despite multistage reconstruction. Implant survival is limited, and revision surgery is the rule rather than the exception.
Zitieren
APA
Cerezal, Á., Gómez, F. G., Lovic, A., Talavera, G., Baíllo, N. F., & Pizones, J. (2026). Difficulties Managing Spinal Deformities in Congenital Insensitivity to Pain with Anhidrosis. JBJS Case Connector, 16(4). https://doi.org/10.2106/jbjs.cc.26.00441
Vancouver
Cerezal Á, Gómez FG, Lovic A, Talavera G, Baíllo NF, Pizones J. Difficulties Managing Spinal Deformities in Congenital Insensitivity to Pain with Anhidrosis. JBJS Case Connector. 2026;16(4). doi:10.2106/jbjs.cc.26.00441
BibTeX
@article{Cerezal2026,
author = {Cerezal, Álvaro and Gómez, Fernando González and Lovic, Aleksandar and Talavera, Gloria and Baíllo, Nicomedes Fernández and Pizones, Javier},
title = {Difficulties Managing Spinal Deformities in Congenital Insensitivity to Pain with Anhidrosis},
journal = {JBJS Case Connector},
year = {2026},
volume = {16},
number = {4},
doi = {10.2106/jbjs.cc.26.00441}
}
EUVIMED